FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagefhir.ke.nccp
Resource TypeCodeSystem
IdCodeSystem-sha-interventions-cs.json
FHIR VersionR4
Sourcehttps://build.fhir.org/ig/IntelliSOFT-Consulting/nccpFHIRIG/CodeSystem-sha-interventions-cs.html
URLhttps://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs
Version0.1.0
Statusactive
Date2026-06-08T10:30:33+00:00
NameSHAInterventionsCS
TitleKenya SHA Oncology Interventions Code System
Realmus
Authorityhl7
DescriptionSocial Health Authority (SHA) benefit package codes for oncology interventions.
Contentcomplete

Resources that use this resource

ValueSet
fhir.ke.nccp#currentnccp-sha-interventions-vsKenya SHA Oncology Interventions Value Set

Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem sha-interventions-cs

This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs defines the following codes:

CodeDisplayDefinition
SHA-CHEMO-FIRST-LINE SHA: Chemotherapy — First LineFirst-line chemotherapy regimen.
SHA-CHEMO-SECOND-LINE SHA: Chemotherapy — Second LineSecond-line or salvage chemotherapy.
SHA-CHEMO-ADJUVANT SHA: Chemotherapy — AdjuvantPost-surgery adjuvant chemotherapy.
SHA-CHEMO-NEO-ADJUVANT SHA: Chemotherapy — Neo-adjuvantPre-surgery neo-adjuvant chemotherapy.
SHA-CHEMO-PALLIATIVE SHA: Chemotherapy — PalliativePalliative intent chemotherapy.
SHA-RT-RADICAL SHA: Radiotherapy — RadicalCurative radiotherapy course.
SHA-RT-PALLIATIVE SHA: Radiotherapy — PalliativePalliative radiotherapy course.
SHA-RT-ADJUVANT SHA: Radiotherapy — AdjuvantPost-surgery adjuvant radiotherapy.
SHA-RT-CONCURRENT-CRT SHA: Concurrent Chemo-RadiotherapyChemotherapy and radiotherapy delivered concurrently.
SHA-SURGERY-CURATIVE SHA: Surgery — CurativeCancer surgery with curative intent.
SHA-SURGERY-PALLIATIVE SHA: Surgery — PalliativePalliative or debulking surgery.
SHA-BMT-AUTOLOGOUS SHA: BMT — AutologousAutologous bone marrow / stem cell transplant.
SHA-BMT-ALLOGENEIC SHA: BMT — AllogeneicAllogeneic bone marrow / stem cell transplant.
SHA-HORMONAL-THERAPY SHA: Hormonal TherapyHormone therapy for hormone-responsive cancers.
SHA-TARGETED-THERAPY SHA: Targeted TherapyTargeted molecular therapy / immunotherapy.
SHA-SUPPORTIVE-CARE SHA: Supportive / Supportive CareSupportive medications and G-CSF.
SHA-PAIN-MANAGEMENT SHA: Palliative Pain ManagementOpioid and pain management for cancer.
SHA-CANCER-SCREENING SHA: Cancer ScreeningCovered cancer screening tests (cervical, breast).
SHA-BIOPSY SHA: Diagnostic BiopsyTissue biopsy for cancer diagnosis.
SHA-IMAGING SHA: Oncology Diagnostic ImagingCT, MRI, PET-CT for staging or response.
SHA-ONCOLOGY-CONSULT SHA: Oncology ConsultationSpecialist oncology consultation.
SHA-MDT SHA: MDT MeetingMultidisciplinary tumour board review.
SHA-PATHOLOGY SHA: Pathology / HistopathologyHistopathology, IHC, or molecular diagnostics.
SHA-RT-DOSE-PER-FRACTION SHA: RT Dose Per FractionRadiation dose delivered per fraction (Gy).
SHA-RT-TOTAL-FRACTIONS SHA: RT Total Fractions DeliveredTotal number of radiation fractions delivered.
SHA-SUSPECTED-CANCER-TYPE SHA: Suspected Cancer TypeType of cancer suspected at screening/referral.
SHA-SUSPICION-LEVEL SHA: Cancer Suspicion LevelClinical level of suspicion for malignancy.
SHA-REASON-FOR-SUSPICION SHA: Reason for SuspicionReason underpinning the cancer suspicion.
SHA-PRESENTING-SYMPTOMS SHA: Presenting SymptomsSymptoms presented by the patient.
SHA-DIAGNOSTIC-WORKUP SHA: Planned Diagnostic WorkupDiagnostic investigations planned for confirmation.

Source1

{
  "resourceType": "CodeSystem",
  "id": "sha-interventions-cs",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
  "version": "0.1.0",
  "name": "SHAInterventionsCS",
  "title": "Kenya SHA Oncology Interventions Code System",
  "status": "active",
  "experimental": false,
  "date": "2026-06-08T10:30:33+00:00",
  "publisher": "Digital Health Agency (DHA), Kenya",
  "contact": [
    {
      "name": "Digital Health Agency (DHA), Kenya",
      "telecom": [
        {
          "system": "url",
          "value": "https://dha.go.ke"
        },
        {
          "system": "email",
          "value": "info@dha.go.ke"
        }
      ]
    },
    {
      "name": "Digital Health Agency Kenya – FHIR Team",
      "telecom": [
        {
          "system": "email",
          "value": "info@dha.go.ke",
          "use": "work"
        },
        {
          "system": "url",
          "value": "https://dha.go.ke",
          "use": "work"
        }
      ]
    }
  ],
  "description": "Social Health Authority (SHA) benefit package codes for oncology interventions.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "KE",
          "display": "Kenya"
        }
      ]
    }
  ],
  "caseSensitive": true,
  "content": "complete",
  "count": 30,
  "concept": [
    {
      "code": "SHA-CHEMO-FIRST-LINE",
      "display": "SHA: Chemotherapy — First Line",
      "definition": "First-line chemotherapy regimen."
    },
    {
      "code": "SHA-CHEMO-SECOND-LINE",
      "display": "SHA: Chemotherapy — Second Line",
      "definition": "Second-line or salvage chemotherapy."
    },
    {
      "code": "SHA-CHEMO-ADJUVANT",
      "display": "SHA: Chemotherapy — Adjuvant",
      "definition": "Post-surgery adjuvant chemotherapy."
    },
    {
      "code": "SHA-CHEMO-NEO-ADJUVANT",
      "display": "SHA: Chemotherapy — Neo-adjuvant",
      "definition": "Pre-surgery neo-adjuvant chemotherapy."
    },
    {
      "code": "SHA-CHEMO-PALLIATIVE",
      "display": "SHA: Chemotherapy — Palliative",
      "definition": "Palliative intent chemotherapy."
    },
    {
      "code": "SHA-RT-RADICAL",
      "display": "SHA: Radiotherapy — Radical",
      "definition": "Curative radiotherapy course."
    },
    {
      "code": "SHA-RT-PALLIATIVE",
      "display": "SHA: Radiotherapy — Palliative",
      "definition": "Palliative radiotherapy course."
    },
    {
      "code": "SHA-RT-ADJUVANT",
      "display": "SHA: Radiotherapy — Adjuvant",
      "definition": "Post-surgery adjuvant radiotherapy."
    },
    {
      "code": "SHA-RT-CONCURRENT-CRT",
      "display": "SHA: Concurrent Chemo-Radiotherapy",
      "definition": "Chemotherapy and radiotherapy delivered concurrently."
    },
    {
      "code": "SHA-SURGERY-CURATIVE",
      "display": "SHA: Surgery — Curative",
      "definition": "Cancer surgery with curative intent."
    },
    {
      "code": "SHA-SURGERY-PALLIATIVE",
      "display": "SHA: Surgery — Palliative",
      "definition": "Palliative or debulking surgery."
    },
    {
      "code": "SHA-BMT-AUTOLOGOUS",
      "display": "SHA: BMT — Autologous",
      "definition": "Autologous bone marrow / stem cell transplant."
    },
    {
      "code": "SHA-BMT-ALLOGENEIC",
      "display": "SHA: BMT — Allogeneic",
      "definition": "Allogeneic bone marrow / stem cell transplant."
    },
    {
      "code": "SHA-HORMONAL-THERAPY",
      "display": "SHA: Hormonal Therapy",
      "definition": "Hormone therapy for hormone-responsive cancers."
    },
    {
      "code": "SHA-TARGETED-THERAPY",
      "display": "SHA: Targeted Therapy",
      "definition": "Targeted molecular therapy / immunotherapy."
    },
    {
      "code": "SHA-SUPPORTIVE-CARE",
      "display": "SHA: Supportive / Supportive Care",
      "definition": "Supportive medications and G-CSF."
    },
    {
      "code": "SHA-PAIN-MANAGEMENT",
      "display": "SHA: Palliative Pain Management",
      "definition": "Opioid and pain management for cancer."
    },
    {
      "code": "SHA-CANCER-SCREENING",
      "display": "SHA: Cancer Screening",
      "definition": "Covered cancer screening tests (cervical, breast)."
    },
    {
      "code": "SHA-BIOPSY",
      "display": "SHA: Diagnostic Biopsy",
      "definition": "Tissue biopsy for cancer diagnosis."
    },
    {
      "code": "SHA-IMAGING",
      "display": "SHA: Oncology Diagnostic Imaging",
      "definition": "CT, MRI, PET-CT for staging or response."
    },
    {
      "code": "SHA-ONCOLOGY-CONSULT",
      "display": "SHA: Oncology Consultation",
      "definition": "Specialist oncology consultation."
    },
    {
      "code": "SHA-MDT",
      "display": "SHA: MDT Meeting",
      "definition": "Multidisciplinary tumour board review."
    },
    {
      "code": "SHA-PATHOLOGY",
      "display": "SHA: Pathology / Histopathology",
      "definition": "Histopathology, IHC, or molecular diagnostics."
    },
    {
      "code": "SHA-RT-DOSE-PER-FRACTION",
      "display": "SHA: RT Dose Per Fraction",
      "definition": "Radiation dose delivered per fraction (Gy)."
    },
    {
      "code": "SHA-RT-TOTAL-FRACTIONS",
      "display": "SHA: RT Total Fractions Delivered",
      "definition": "Total number of radiation fractions delivered."
    },
    {
      "code": "SHA-SUSPECTED-CANCER-TYPE",
      "display": "SHA: Suspected Cancer Type",
      "definition": "Type of cancer suspected at screening/referral."
    },
    {
      "code": "SHA-SUSPICION-LEVEL",
      "display": "SHA: Cancer Suspicion Level",
      "definition": "Clinical level of suspicion for malignancy."
    },
    {
      "code": "SHA-REASON-FOR-SUSPICION",
      "display": "SHA: Reason for Suspicion",
      "definition": "Reason underpinning the cancer suspicion."
    },
    {
      "code": "SHA-PRESENTING-SYMPTOMS",
      "display": "SHA: Presenting Symptoms",
      "definition": "Symptoms presented by the patient."
    },
    {
      "code": "SHA-DIAGNOSTIC-WORKUP",
      "display": "SHA: Planned Diagnostic Workup",
      "definition": "Diagnostic investigations planned for confirmation."
    }
  ]
}